The 8th edition American Joint Committee on Cancer staging for hepato-pancreato-biliary cancer: A review and update

57Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Context.—Cancer staging provides critical information for patients and treating physicians to battle against cancer, predict prognosis, and guide treatment decisions. The American Joint Committee on Cancer (AJCC) staging system uses a tumor, node, metastasis (TNM) scoring algorithm and is the foremost classification system for adult cancers. This system is updated every 6 to 8 years to allow sufficient time for implementation of changes and for relevant examination and discussion of data validating those changes in staging. Objective.—To review the updates in the 8th edition American Joint Committee on Cancer staging system on hepato-pancreato-biliary cancer. Data Sources.—Literature review. Conclusions.—The 8th edition, published in 2016 and implemented on January 1, 2018, has been in use for approximately 3 years. Compared with the 7th edition, some of the changes are quite radical. This review aims to provide a summary of the changes/updates of the 8th edition with focus on hepato-pancreato-biliary cancers, and evaluate its performance through literature review.

Cite

CITATION STYLE

APA

Liao, X., & Zhang, D. (2021). The 8th edition American Joint Committee on Cancer staging for hepato-pancreato-biliary cancer: A review and update. Archives of Pathology and Laboratory Medicine, 145(5), 543–553. https://doi.org/10.5858/arpa.2020-0032-RA

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free